Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LACunar Intervention Trial 3
ISRCTN44436843Phase 3Recruiting
- Sponsor
- University of Edinburgh
- Start
- Mar 2025
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of isosorbide mononitrate and cilostazol in lacunar infarct (4 arms), sponsored by University of Edinburgh. Started Mar 2025; status: recruiting.
02
Drugs
isosorbide mononitratecilostazol
03
Conditions
lacunar infarct
Beyond the preview
Go deeper on ISRCTN44436843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN44436843.